I don’t understand what you are saying here. I thought EMR want a high price to convert their notes at the change in control price. ERM currently have an average cost in hfr of circa $1. Why would they buy anymore at a lower price they want to maximise the price to convert there notes and recover losses on existing shares they hold.
I don’t understand what you are saying here. I thought EMR want...
Add HFR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $124.5M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 29.0¢ | $52.80K | 176.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99915 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 34205 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| HFR (ASX) Chart |